October 23, 2026 08:01 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Tiger Shroff, not Salman Khan, was the main target, probe reveals shocking details | Dammam airport attack: Indian killed, two compatriots injured as Saudi Arabia faces fresh strikes | ‘Among others’: Macron takes swipe at Trump over France unrest, calls foreign leaders’ remarks ‘stupid’ | ‘Specific threat-related inputs’: Delhi Police blocks Diljit Dosanjh’s Delhi concert | ‘Barbaad kare alfaz mere’: Ranbir Kapoor apologises for Dussehra gaffe in Kolkata | Delhi court releases CJP's Saurav Das and Ashutosh Ranka after 7 days in custody | ‘We are seeing what is happening outside our country’: Delhi HC judge’s remark as CJP leaders Saurav Das and Ashutosh Ranka withdraw custody plea | Salman Khan was the original target? Tiger Shroff firing probe reveals shocking twist | ‘UN experts are an oxymoron’: Marco Rubio takes swipe at UN, refuses to comment on India's protests | ‘US ties with no country come at India's expense’: Marco Rubio addresses concerns over Pakistan, China

Mankind Pharma 5th fastest growing company: Report

| | Jan 21, 2015, at 02:34 am
New Delhi, Jan 20 (IBNS): Within a short span of 20 years, Mankind Pharma, has set the Indian pharmaceutical industry astonished by achieving the rank of 5th largest and fastest growing company of India, according to the IMS Health report.
The report states Mankind Pharma has earned revenue of 2700 crores by the month of December 2014 with the growth rate of 18 %. 
 
The category measured and scored the firm’s ability to deliver innovation to market, by objectively measuring Mankind Pharma’s performance.
 
Established in 1995, Meerut-based Mankind Pharma, with a vision of becoming a leading global pharmaceutical company has dedicated itself in developing a wide portfolio of generics and new products, the company said in a statement.
 
With an annual growth of 25%, Mankind Pharma has gained an annual turnover of Rs. 2,700 crore in the fiscal year 2013-2014. In the last 10 years, Mankind has grown at an average of 30%, against an industry average of 12%.
 
R C Juneja, Chairman and Founder, Mankind Pharma, commenting on the achievement said, “With innovation and continuous research and development, we have successfully achieved the prestigious reward. Our unique business model, gives us access to originate products in various markets around the world. We are among the very few Indian pharmaceutical companies that offer a wide range of both generic and innovator products.”
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.